Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: No evidence for prognostic significance

British Journal of Cancer

Volumn 77, Issue 11, 1998, Pages 1842-1847

  Tollenaar, R A E M ^a   Van Krieken, J H J M ^a   Van Slooten, H J ^a   Bruinvels, D J ^a   Nelemans, K M J ^a   Van Den Broek, L J ^a   Hermans, J ^a   Van Dierendonck, J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bcl 2; Colorectal neoplasm; Immunohistochemistry; p53; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN P53;

ADENOMA; ARTICLE; CANCER CELL; CELL NUCLEUS; COLORECTAL CARCINOMA; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

EID: 0031749953     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.306     Document Type: Article

References (49)

1. Astler VB and Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 845-852
2. Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B and Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12
3. Baker SJ, Preisinger AC, Jessup M, Paraskeva C, Markowitz S, Willson JKV, Hamilton S and Vogelstein B (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717-7722
4. Baretton GB, Diebold J, Christoforis G, Vogt M, Müller C, Dopfer K, Schneiderbanger K, Schmidt M and Löhrs U (1996) Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas; aspects of carcinogenesis and prognostic significance. Cancer 77: 255-264
5. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR and Jones RJ (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55: 1811-1816
6. Blagosklonny MV (1997) Loss of function and p53 stabilization. Oncogene 15: 1889-1893
7. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ and Lee KC (1994) Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86: 681-687
8. Bosari S, Moneghini L, Graziani D, Lee AKC, Murray JJ, Coggi G and Viale G (1995) Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Human Pathol 26: 534-540
9. Bronner MP, Culin C, Ree JC and Furth EE (1995) The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146: 20-26
10. Campo E, de la Calle-Martin O, Miquel R, Palacin A, Romero M, Fabregat V, Vives J, Cardesa A and Yague J (1991) Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. Cancer Res 51:4436-4442
11. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
12. Flohil CC, Janssen PA and Bosman FT (1996) Expression of Bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon. J Pathol 178: 393-397
13. Hague A, Moorghen M, Hicks D, Chapman M and Paraskeva C (1994) BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 9: 3367-3370
14. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ and Thomas G (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106: 42-48
15. Hanski C, Bornhoeft G, Shimoda T, Hanski M-L, Lane DP, Stein H and Riecken E-O (1992) Expression of p53 protein in invasive colorectal carcinomas of different histological types. Cancer 70: 2772-2777
16. Hockenbery DM, Zutter M, Hickey W, Nahm M and Korsmeyer SJ (1991) Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965
17. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) P53 mutations in human cancers. Science 253: 49-53
18. Horne GM, Anderson JJ, Tiniakos DG, McIntosh GG, Thomas MD, Angus B, Henry JA, Lennard TWJ and Horne CWH (1996) P53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistry. Br J Cancer 73: 29-35
19. Huang DCS, O'Reilly LA, Strasser A and Cory S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J 16: 4628-4638
20. Iino H, Fukayama M, Maeda Y, Koike M, Mori T, Takahashi T, Kikuchi-Yanoshita R, Miyaki M, Mizuno S and Watanabe S (1994) Molecular genetics for clinical management of colorectal cancer. Cancer 73: 1324-1331
21. Jass JR (1992) Lymphocytic infiltration and survival in rectal cancer. J Clin Pathol, 39, 585-589
22. Kaklamanis L, Gatter KC, Mortensen N, Baigrie RJ, Herjet A, Lane DP and Harris AL (1993) p53 expression in colorectal adenomas. Am J Pathol 142: 87-93
23. Kastrinakis WV, Ramchurren N, Rieger KM, Hess DT, Loda M, Steele G and Summerhayes IC (1995) Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 11: 647-652
24. Kern SE, Fearon ER, Tersmette KWF, Enterline JP, Leppert M, Nakamura Y, White R, Vogelstein B and Hamilton SR (1989) Allelic loss in colorectal carcinoma. JAMA 261: 3099-3103
25. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H, Fukayama M, Koike M, Mori T, Sakuraba H, Fukunari H, Iwama T and Miyaki M (1992) Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res 52: 3965-3971
26. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR and Reed JC (1996) Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 56: 2422-2427
27. Laurent-Puig P, Olschwang S, Remvikos Y, Asselain B, Melot T, Validire P, Muleris M, Girodet J, Salmon RJ and Thomas G (1992) Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 102: 1136
28. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, Weiss H, Brown D, Srivastava S and Grizzle WE (1997) Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 74: 346-358
29. Mazel S, Burtrum and Petrie HT (1996) Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 183: 2219-2226
30. Merrit AJ, Potten CS, Watson AJM, Loh DY, Nakayama K-I, Nakayama K and Hickman JA (1995) Differential expression of bcl-2 in intestinal epithelia; correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Science 108: 2261-2271
31. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D and Barnes DM (1992) Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 101: 183-189
32. Mosnier J-F, Perret AG, Vindimian M, Dumollard JM, Balique JG, Perpoint B and Boucheron S (1996) An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch Pathol Lab Med 120: 654-659
33. Mueller J, Mueller E, Hoepner I, Jütting J, Bethke B, Stolte M and Höfler H (1996) Expression of bcl-2 and p53 in de novo and ex-adenoma colon carcinoma: a comparative immunohistochemical study. J Pathol 180: 259-265
34. Mulder J-WR, Baas IO, Polak MM, Goodman SN and Offerhaus GJA (1995) Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 71: 1257-1262
35. Offerhaus GJA, de Feyter EP, Cornelisse CJ, Tersmette KWF, Fo J, Kern SE, Vogelstein B and Hamilton SR (1992) The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 102: 1612-1619
36. Öfner D, Riehemann K, Maier H, Riedmann B, Nehoda H, Tötsch M, Böcker W, Jasani B and Schmid KW (1995) Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer 72: 981-985
37. Ookawa K, Sakamoto M, Hirohashi S, Yoshida Y, Sugimura T, Terada M and Yokota J (1993) Concordant p53 and DCC alterations and allelic losses on chromosome 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer 53: 382-387
38. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC and Mason DY (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137: 225-232
39. Pietenpol JA, Papadopoulos N, Markowitz S, Wilson JK, Kinzler KW and Vogelstein B (1994) Paradoxical inhibition of solid tumor cell growth by bcl2. Cancer Res 54: 3714-3717
40. Pricolo VE, Finkelstein SD, Wu T-T, Keller G, Bakker A, Swalsky PA and Bland KI (1996) Prognostic value of TP53 and K-ras-3 mutational analysis in stage III carcinoma of colon. Am J Surg 171: 41-46
41. Rampino M, Yamamoto H, Ionov Y, Li Y, Sawai M, Reed JC and Perucho M (1997) Somatic mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969
42. Schneider HJ, Sampson SA, Cunningham D, Norman AR, Andreyev HJN, Tilsed JVT and Clarke PA (1997) Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas. Br J Cancer 75: 427-431
43. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ and Levin B (1995) bcl-2 and p53 oncogene expression during colorectal tumorigenesis. Cancer Res 55: 237-241
44. Starzynska T, Bromley M, Ghosh A and Stern PL (1992) Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 66: 558-562
45. Sun X-F, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T and Nordenskjöld B (1992) Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369-1373
46. Tollenaar RAEM (1997) Aspects of tumour progression in colorectal carcinoma. Thesis, Leiden, The Netherlands
47. Van Slooten H-J, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard A-M, Delobelle-Deroide A, van de Velde CJH and Van De Vijver MJ (1996) Expression of BCL-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br J Cancer 74: 78-85
48. Ward RL, Todd AV, Santiago F, O'Connor T and Hawkins NJ (1997) Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis. Cancer 79, 1106-1113
49. Watson AJM, Merrit AJ, Jones LS, Askew JN, Anderson E, Becciolini A, Balzi M, Potten CS and Hickman JA (1996) Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br J Cancer 73: 889-895